magnesium sulfate has been researched along with Deafness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ashwood, P; Crowther, CA; Haslam, R; Middleton, PF; Wilkinson, D | 1 |
| Chiba, Y; Hosono, T; Suzuki, M | 1 |
1 trial(s) available for magnesium sulfate and Deafness
| Article | Year |
|---|---|
Magnesium sulphate at 30 to 34 weeks' gestational age: neuroprotection trial (MAGENTA)--study protocol.
Topics: Blindness; Calcium Channel Blockers; Cerebral Palsy; Child Behavior; Child, Preschool; Deafness; Developmental Disabilities; Female; Gestational Age; Health Status; Humans; Infant; Infant Mortality; Infant, Newborn; Infant, Premature; Infant, Premature, Diseases; Magnesium Sulfate; Perinatal Mortality; Pregnancy; Premature Birth; Psychological Tests; Research Design; Stillbirth | 2013 |
1 other study(ies) available for magnesium sulfate and Deafness
| Article | Year |
|---|---|
Contraindication of magnesium sulfate in a pregnancy complicated with late-onset diabetes mellitus and sensory deafness due to mitochondrial myopathy.
Topics: Adult; Deafness; Diabetes Mellitus, Type 1; Female; Humans; Magnesium Sulfate; Mitochondrial Myopathies; Muscle Cramp; Obstetric Labor, Premature; Pain; Parity; Pregnancy; Pregnancy Complications; Pregnancy, High-Risk; Tocolytic Agents | 2001 |